NCT07180043View on ClinicalTrials.gov

Propranolol for Pediatric Migraine: A Prospective Clinical Study

NACompletedINTERVENTIONAL
Enrollment

178

Participants

Timeline

Start Date

January 1, 2021

Primary Completion Date

January 1, 2023

Study Completion Date

December 30, 2023

Conditions
Pediatric MigraineHeadache Disorders
Interventions
BEHAVIORAL

Structured Behavioral Therapy

Structured patient education, lifestyle modification counseling, and headache diary maintenance without pharmacological prophylaxis.

DRUG

Propranolol

Oral propranolol, 1-3 mg/kg/day in two divided doses, titrated according to response, for 12 weeks.

Trial Locations (1)

38130

Kayseri University, Kayseri

All Listed Sponsors
lead

Kayseri University

OTHER

NCT07180043 - Propranolol for Pediatric Migraine: A Prospective Clinical Study | Biotech Hunter | Biotech Hunter